GeoPharma, Inc.

Drugmaker announces dismissal of amended class action complaint relating to Mucotrol

Published in Physician Law Weekly, March 1st, 2006

GeoPharma, Inc., (GORX) announced that the amended class action complaint against GeoPharma relating to its announcement of U.S. Food & Drug Administration (FDA) approval for the company's medical device Mucotrol was dismissed on January 27, 2006, with prejudice, by a judge in the United States District Court for the Southern District of New York and therefore the case is now closed.

Plaintiffs' earlier complaint was dismissed by the Court on September 30, 2005.

GeoPharma, Inc., is a pharmaceutical company specializing in the manufacturing and distribution of over-the-counter, nutritional, generic drug, and functional food products.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Physician Law Weekly

Source: Physician Law Weekly (2006-03-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry